Authors
Loading...
Randomized trial examines FOXC1's role in smooth muscle cell behavior in vascular disease, suggesting therapeutic targets.
Rykaczewska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: